Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of Enzyme Inhibition and Medicinal Chemistry|July 25, 2022
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, <i>in silico</i> studies, and antiproliferative evaluationMohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, et al.Plos One|September 4, 2025
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.Journal of Biomolecular Structure & Dynamics|June 1, 2023
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: <i>in silico</i> and <i>in vitro</i> evaluationsMohammed A Dahab, Hazem A Mahdy, Hazem Elkady, et al.Bioorganic Chemistry|December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducersHazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 17, 2022
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesEslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, et al.Computational Biology and Chemistry|September 15, 2023
New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studiesHazem Elkady, Abdelrahman A Abuelkhir, Mahmoud Rashed, et al.Heliyon|February 1, 2024
Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: <i>In vitro</i> and <i>in silico</i> studiesIbrahim H Eissa, Hazem Elkady, Mahmoud Rashed, et al.Bioorganic Chemistry|October 31, 2020
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluationIbrahim H Eissa, Abdel-Ghany A El-Helby, Hazem A Mahdy, et al.Pageof 5